Skip to main content
Veterinary Medicines

VIRBACTAN 150 MG INTRAMAMMARY OINTMENT

Authorised
  • Cefquinome sulfate

Product identification

Medicine name:
VIRBACTAN 150 MG INTRAMAMMARY OINTMENT
Virbactan 150 mg ενδομαστική αλοιφή
Active substance:
  • Cefquinome sulfate
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefquinome sulfate
    177.80
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        2
        day
      • Milk
        36
        day
      • Milk
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DE90
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • Box of 1 sachet of 4 applicators and 4 cleaning towels
  • Box of 5 sachets of 4 applicators and 20 cleaning towels
  • Box of 6 sachets of 4 applicators and 24 cleaning towels
  • Box of 15 sachets of 4 applicators and 60 cleaning towels
  • Box of 30 sachets of 4 applicators and 120 cleaning towels

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Virbac
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00089V
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0148/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 12/12/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."